Q1 2018
Released May 3, 2018, after the close
10-Q filed May 3, 2018, 33 days after period end · 0001237831-18-000023
Q1 2018 · 10-Q
Revenue$174.41M$174.41M +11.9% vs Q1 2017−0.9% vs Q4 2017
Net Income$39.54M$39.54M +37.7% vs Q1 2017+62.2% vs Q4 2017
EPS Diluted$0.39$0.39 +30.0% vs Q1 2017+56.0% vs Q4 2017
Gross Profit$136,441,000+13.5%
Operating Income$45,633,000+13.2%
Operating Cash Flow$52,295,000−2.2%
Free Cash Flowderived$39,921,000−4.8%
Margins · derived
Gross margin78.2%+1.1 pt vs Q1 2017
Operating margin26.2%+0.3 pt vs Q1 2017
Net margin22.7%+4.2 pt vs Q1 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $174.41M | $155.81M | $139.26M | $131.60M |
| Net Income | $39.54M | $28.71M | $28.01M | $24.65M |
| EPS Diluted | $0.39 | $0.30 | $0.29 | $0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR